ERN1 and systemic lupus erythematosus: IRE-1 is a central regulator of B cell differentiation [54,55,56,57], and B cell hyperactivity is a defining pathogenic event in SLE [3,58], with B cell depletion therapies being considered for the treatment of the disorder [59].